Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1
OBR Daily - Our Oncology Focused E-News Service

Register for OBR daily



Warning: Missing argument 1 for showSidebarBanner(), called in /home2/don/public_html/sidebar_obrgreen.php on line 38 and defined in /home2/don/public_html/include/banners.php on line 243
KH_PatientWebinar_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GERN $3.70 0.4500 +13.85%
GALE $2.07 0.2100 +11.29%
FATE $4.23 0.3800 +9.87%
PGNX $6.77 0.3500 +5.45%
NLNK $35.33 1.8100 +5.40%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARGS $8.50 -0.4100 -4.60%
EPZM $22.49 -1.0700 -4.54%
CLVS $48.60 -2.1900 -4.31%
CPXX $1.86 -0.0800 -4.12%
GALT $4.20 -0.1500 -3.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

VBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)

(CNNMoney) Nov 13, 2014 - VBL Therapeutics today announced positive preliminary results from its ongoing Phase 2 trial of VB-111 in patients with recurrent glioblastoma (rGBM).
read article 



Personalized Genetic Test Could Predict Prostate Cancer Recurrence: Researchers

(Vancouver Sun/The Canadian Press) Nov 13, 2014 - Canadian researchers have developed a genetic test to identify which men are at highest risk for recurrence of prostate cancer following localized treatment with surgery or radiation therapy.
read article 



Cancer-Killing Virus Plus Chemotherapy Drug Might Treat Recurrent Ovarian Cancer

(OSUCCC - James) Nov 11, 2014 - Researchers showed that the oncolytic virus called 34.5ENVE has significant antitumor activity against ovarian cancer on its own, and that its activity is even greater when combined with the chemotherapy drug doxorubicin in an animal model of disseminated peritoneal ovarian cancer.
read press release 



Gene Sequencing Projects Link Two Mutations to Ewing Sarcoma Subtype With Poor Prognosis

(St. Jude Children's Research Hospital) Nov 12, 2014 - An international collaboration has identified frequent mutations in two genes that often occur together in Ewing sarcoma (EWS) and that define a subtype of the cancer associated with reduced survival.
read press release 



2nd Surgeries After Breast Cancer Lumpectomy

(WebMD/HealthDay News) Nov 12, 2014 - In a study of more than 240,000 women who had breast conservation surgery for breast cancer, nearly 25 percent needed a second operation, a new study finds.
read article 



Too Many Women Face "Unnecessary" Repeat Breast Surgery

(UWHealth) Nov 12, 2014 - A large national review shows that about a quarter of women who opt for lumpectomy to preserve their breasts wind up having further surgery to reduce risk of the cancer returning.
read press release 



Costly Cancer Drugs May Be Cut From Special Funding List

(The Guardian [UK]) Nov 12, 2014 - More than 40 cancer drugs being paid for out of the government’s Cancer Drugs Fund are to be reassessed to decide if they are worth the money.
read article 



U of L, UK Join Forces Against Lung Cancer

(The Courier-Journal [Louisville, KY]) Nov 12, 2014 - The universities of Kentucky and Louisville and the Lung Cancer Alliance announced Wednesday that they are forming the Kentucky LEADS Collaborative, a first-of-its-kind project that aims to find lung cancer earlier and improve the quality of life for patients and caregivers.
read article 



Some Patients Are Getting Colonoscopies Too Often

(Boston Globe) Nov 10, 2014 - A recently published study revealed that some patients get the exam too often, exposing them to unneeded risks and raising costs.
read article (free registration required) 



Amgen Psoriasis Drug Tops J&J's Stelara in Phase III Study

(Reuters) Nov 11, 2014 - - Amgen Inc said on Tuesday that its experimental psoriasis drug, brodalumab, met all the goals of a late-stage study, clearing the rough skin patches associated with the disease more thoroughly than Johnson & Johnson's Stelara and a placebo.
read article 



Merck Braces for Study on Medicines Worth $4 Billion a Year

(Bloomberg) Nov 12, 2014 - Merck & Co.’s pills Zetia and Vytorin generated more than $21 billion for the company since they were introduced more than a decade ago. Next week, doctors will find out if they actually save lives in addition to lowering cholesterol.
read article 



AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study

(Bloomberg) Nov 11, 2014 - AbbVie Inc.’s hepatitis C treatment cured 97 percent of patients who had received a liver transplant, a study showed today, potentially adding a valuable option for a group that’s highly vulnerable to the disease.
read article 



FDA Will Test Whether Consumers Absorb Risk Info in TV Drug Ads

(Wall Street Journal/Pharmalot blog) Nov 12, 2014 - What do you think when you repeatedly see the same ad for a prescription drug? The FDA wants to know.
read article (paid subscription required) 



Recipients of Cancer Clinical Investigator Team Leadership Awards Announced

(NCI News Note) Nov 12, 2014 - NCI’s Cancer Clinical Investigator Team Leadership Awards recognize and support outstanding mid-career clinical investigators at NCI-Designated Cancer Centers who participate extensively in NCI-funded collaborative clinical trials and whose leadership, participation, and activities promote a culture of successful clinical research.
read article 



Susan G. Komen® Launches National Patient Navigation Program to Improve Breast Cancer Outcomes for Underserved Women and Men

(Susan G. Komen) Nov 12, 2014 – In its ongoing effort to reduce breast cancer deaths by ensuring access to timely, quality breast cancer care, Susan G. Komen today announced a new nationwide program, funded by Walgreens and its customers, for patient navigation services that guide women and men through diagnosis and treatment.
read press release 



Biocept Launches Lung Cancer Offering

(CNNMoney) Nov 12, 2014 - Biocept, Inc., a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and Circulating Tumor Cells (CTCs), today announced the launch of its lung cancer liquid biopsy testing that will be performed at the Company's CLIA-certified and CAP-accredited laboratory.
read article 



Advaxis Submits Investigational New Drug Application for Phase 1/2 Study of ADXS-HPV and MedImmune's MEDI4736 for the Treatment of HPV-Associated Cervical and Head & Neck Cancer

(TheStreet) Nov 12, 2014 - Advaxis, Inc. today announced that the Company has submitted an Investigational New Drug application (IND) to the FDA to conduct a Phase 1/2 study of ADXS-HPV (ADXS11-001) alone or in combination with MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, for the treatment of cervical cancer and head and neck cancer.
read article 



Recent Increase in Reporting of Financial Conflicts of Interest

(HCPLive/HealthDay News) Nov 11, 2014 — Reporting of financial conflicts of interest (FCOIs) has increased over time in clinical practice guidelines (CPGs) and consensus statements (CSs) for the treatment of common solid tumors, according to research published online Nov. 10 in the Journal of Clinical Oncology.
read article 



Expert Opinion: Medicare to Cover Lung Cancer Screening

(MedPage Today) Nov 11, 2014 - Lung cancer experts react to the CMS decision.
read article (free registration required) 



Bayer Healthcare Resumes Production of Xofigo

(SNMMI) Nov 6, 2014 - Bayer Healthcare has resumed production of Xofigo® (radium Ra 223 dichloride). The initial lot of Xofigo has been released and is available to begin patient treatment this week. Production for new patients resumes on Monday, Nov. 17.
read article 



Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax (nelipepimut-S) in Combination With Herceptin (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients

(Galena Biopharma) Nov 11, 2014 - Galena Biopharma, Inc. today announced the dosing of the first patient in a new NeuVax™ (nelipepimut-S) Phase 2 clinical trial to prevent breast cancer recurrence in high risk HER2 3+ and/or HER2 gene-amplified breast cancer patients in combination with Herceptin® (trastuzumab; Genentech/Roche).
read corporate press release 



New Test Developed at Dana-Farber/Brigham and Women's Cancer Center Speeds Treatment Decisions for Blood Cancer Patients

(Dana-Farber) Nov 11, 2014 - In a major advance in the care of patients with leukemia and other blood disorders, physicians at Dana-Farber/Brigham and Women's Cancer Center have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment.
read press release 



Novel Molecular Imaging Drug Offers Better Detection of Prostate Cancer

(SNMMI) Nov 11, 2014 - A novel study demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone.
read press release 



Hospice Care Lowers Cost and ICU Use in Cancer Patients

(Medscape Medical News) Nov 11, 2014 - Hospice care at the end of life can significantly lower rates of hospitalization, intensive care unit (ICU) admission, and invasive procedures for cancer patients, according to a new study. Not surprisingly, it can also significantly lower healthcare costs.
read article (free registration required) 



Phone Counseling Helps Rural Women with Cancer Gene Tests

(U.S. News & World Report/HealthDay News) Nov 11, 2014 — Telephone counseling on genetic testing is as effective as in-person counseling for women at high risk for breast or ovarian cancer, a new study finds.
read article